Gabelli Funds’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-44,700
| Closed | -$3.57M | – | 1455 |
|
|
2021
Q1 | $3.57M | Sell |
44,700
-4,500
| -9% | -$351K | 0.02% | 591 |
|
|
2020
Q4 | $3.88M | Sell |
49,200
-15,500
| -24% | -$909K | 0.03% | 540 |
|
|
2020
Q3 | $2.84M | Hold |
64,700
| – | – | 0.02% | 586 |
|
|
2020
Q2 | $2.86M | Sell |
64,700
-327
| -0.5% | -$12.2K | 0.02% | 578 |
|
|
2020
Q1 | $2.33M | Sell |
65,027
-1,400
| -2% | -$79.6K | 0.02% | 600 |
|
|
2019
Q4 | $4.71M | Sell |
66,427
-34,000
| -34% | -$2.47M | 0.03% | 512 |
|
|
2019
Q3 | $7.51M | Hold |
100,427
| – | – | 0.05% | 403 |
|
|
2019
Q2 | $8.1M | Sell |
100,427
-2,573
| -2% | -$181K | 0.05% | 396 |
|
|
2019
Q1 | $6.89M | Buy |
103,000
+600
| +0.6% | +$45.4K | 0.04% | 442 |
|
|
2018
Q4 | $7.62M | Buy |
102,400
+1,400
| +1% | +$116K | 0.05% | 395 |
|
|
2018
Q3 | $9.3M | Buy |
101,000
+1,000
| +1% | +$95.3K | 0.05% | 401 |
|
|
2018
Q2 | $9.84M | Sell |
100,000
-4,000
| -4% | -$447K | 0.06% | 386 |
|
|
2018
Q1 | $11.6M | Sell |
104,000
-9,000
| -8% | -$1.01M | 0.07% | 347 |
|
|
2017
Q4 | $11.6M | Sell |
113,000
-19,000
| -14% | -$1.89M | 0.07% | 360 |
|
|
2017
Q3 | $12.4M | Sell |
132,000
-2,000
| -1% | -$158K | 0.07% | 343 |
|
|
2017
Q2 | $10.4M | Sell |
134,000
-13,500
| -9% | -$1.01M | 0.06% | 370 |
|
|
2017
Q1 | $11.8M | Sell |
147,500
-12,500
| -8% | -$993K | 0.07% | 353 |
|
|
2016
Q4 | $12.6M | Sell |
160,000
-26,000
| -14% | -$2.02M | 0.07% | 336 |
|
|
2016
Q3 | $14.5M | Sell |
186,000
-9,000
| -5% | -$653K | 0.09% | 309 |
|
|
2016
Q2 | $13.4M | Sell |
195,000
-5,000
| -3% | -$345K | 0.08% | 329 |
|
|
2016
Q1 | $14.3M | Sell |
200,000
-15,000
| -7% | -$942K | 0.09% | 310 |
|
|
2015
Q4 | $13.4M | Hold |
215,000
| – | – | 0.08% | 329 |
|
|
2015
Q3 | $12.2M | Sell |
215,000
-2,000
| -0.9% | -$106K | 0.07% | 351 |
|
|
2015
Q2 | $11.6M | Hold |
217,000
| – | – | 0.06% | 397 |
|
|
2015
Q1 | $10.3M | Sell |
217,000
-1,000
| -0.5% | -$44.3K | 0.05% | 422 |
|
|
2014
Q4 | $9.43M | Sell |
218,000
-1,006
| -0.5% | -$41.1K | 0.05% | 460 |
|
|
2014
Q3 | $7.53M | Hold |
219,006
| – | – | 0.04% | 497 |
|
|
2014
Q2 | $8.02M | Hold |
219,006
| – | – | 0.04% | 496 |
|
|
2014
Q1 | $7.38M | Hold |
219,006
| – | – | 0.04% | 490 |
|
|
2013
Q4 | $7.43M | Hold |
219,006
| – | – | 0.04% | 475 |
|
|
2013
Q3 | $6.97M | Sell |
219,006
-110,120
| -33% | -$2.93M | 0.04% | 475 |
|
|
2013
Q2 | $7.43M | Buy |
+329,126
| New | +$7.13M | 0.05% | 443 |
|
Gabelli Funds's CMD Position: Q2 2021 in Review
Gabelli Funds sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 44,700 shares — an estimated $3.57M sold.
Gabelli Funds first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $14.5M in Q3 2016. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Gabelli Funds reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Gabelli Funds sold 44,700 Cantel Medical Corporation shares in Q2 2021, an estimated $3.57M.
- Gabelli Funds first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Gabelli Funds's Cantel Medical Corporation position peaked at $14.5M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Gabelli Funds's 13F filing for Q2 2021, filed 13 Aug 2021.